Robert Moghim, MD
Pain Medicine · Golden, CONPI 1245282862
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $202,158 of the $272,816 with a category attached, or 74.1%. 36 manufacturers reported payments, led by Curonix LLC at 57.3% of the total. Among pain medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 706 payments — averaging $386.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curonix LLC$156K
- Genesys Orthopedics Systems, L.L.C.$30K
- Stimwave Technologies Incorporated$28K
- Abbott$22K
- Painteq LLC$21K
- Saluda Medical Americas, Inc.$4K
- plus $12K from 30 others
Across 18 payments — averaging $2092.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Curonix LLC$30K
- Stimwave Technologies Incorporated$6K
- Painteq LLC$2K
What the payments were for
- Consulting fees$202,15874%
- Speaking & faculty fees$6,7752%
- Travel & lodging$29,34911%
- Food & beverage$19,7877%
- Education$14,7485%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curonix LLC | 184 | $156,419 |
| Genesys Orthopedics Systems, L.L.C. | 25 | $29,657 |
| Stimwave Technologies Incorporated | 23 | $27,810 |
| Abbott | 110 | $22,439 |
| Painteq LLC | 63 | $20,789 |
| Saluda Medical Americas, Inc. | 55 | $4,097 |
| Vertos Medical, Inc. | 24 | $3,550 |
| Medtronic | 22 | $2,020 |
| Boston Scientific | 20 | $1,513 |
| Spinal Simplicity, LLC | 18 | $1,070 |
| AbbVie(2 entities) | 34 | $694 |
| Nevro Corp. | 24 | $577 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $295 |
| Pfizer | 11 | $235 |
| SPR Therapeutics, Inc | 5 | $207 |
| Collegium Pharmaceutical, Inc. | 11 | $200 |
| Globus Medical | 9 | $197 |
| Scilex Pharmaceuticals Inc. | 9 | $173 |
| Zavation Medical Products, LLC | 1 | $114 |
| MML US, Inc. | 6 | $103 |
| Averitas Pharma Inc. | 3 | $101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $95 |
| Vertex | 2 | $56 |
| Lundbeck LLC | 2 | $52 |
| Si-bone, Inc. | 2 | $49 |
| Amgen | 2 | $48 |
| Lilly USA, LLC | 3 | $46 |
| Bioventus LLC | 3 | $45 |
| Sentynl Therapeutics, Inc. | 2 | $28 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| Tonix Medicines, Inc. | 1 | $25 |
| Novartis | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $19 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Kaleo, Inc. | 1 | $16 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$148,023
- SACROILIAC JOINT FUSION SYSTEM$58,753
- StimQ Receiver Stimulator Kit Channel A US w Receiver$32,459
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$32,459
- Freedom 4A Receiver Kit Channel A US w Receiver$32,459
- Freedom 8A Receiver Kit Channel A US w Receiver$32,459
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$32,027
- PAINTEQ$19,085
- PROCLAIM$18,898
- mild Device Kit$3,254
- Evoke$2,489
- Proclaim DRG IPG$1,332
- VANTA ADAPTIVESTIM$1,176
- Superion Indirect Decompression System$1,100
- HA MINUTEMAN G3-R$779
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$432
- Proclaim IPG$223
- INFINITY$189
- INTELLIS ADAPTIVESTIM$168
- INCEPTIV$139
How this compares
$272,816 in reported general payments places this provider in the 95th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 93 | $745 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $521 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $347 |
| Oxycodone Hcl | 24 | $337 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $245 |
| Cyclobenzaprine Hcl | 15 | $70 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Golden
- Karen KnightGolden$5K
- Daniel DrennanGolden$2K
- Jack RentzGreenwood Village$264K
- Donald BernardiniEnglewood$102K
- Haley BurkeAurora$55K
- Amar PatelThornton$47K
- David ColumbusLoveland$30K
- Matthew PouliotFort Collins$26K
- Justin MerkowEnglewood$24K
- Daniel FeldmanBroomfield$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.